Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04757298 · ClinicalTrials.gov registry record · NA
Optimization of a New Adaptive Intervention to Increase COVID-19 Testing
A NA study, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- NA
- Development phase
- 668
- Enrollment target
NCT04757298: Completed NA study, sponsored by University of Illinois at Urbana-Champaign.
NCT04757298 is a NA study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 668 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04757298, a NA study, has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- NA
- Development phase
- 668 participants
- Enrollment target
Study Summary
This study tests an adaptation of the HIV Continuum of Prevention, Care, and Treatment Framework (CoPCT) for use in tracking COVID-19 testing and follow-up in a medically and socially vulnerable population. This study uses an integrated research collaborative framework that facilitates dialogue among researchers, community members, and service providers as a tool for optimizing the adaptive intervention and will take place at the North Jersey Community Research Initiative (NJCRI)
Primary Outcome
For the first stage intervention, the primary outcome is coming to the agency and completing the COVID-19 antigen test one week after completing the baseline.
Interventions
- BEHAVIORAL Navigation Services
- BEHAVIORAL Brief Counseling
- BEHAVIORAL Critical Dialogue
- BEHAVIORAL Referral and Digital Brochure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 668 participants |
| Start Date | 2021-02-12 |
| Est. Completion | 2022-10-25 |
| Phase | NA |
What the finished NCT04757298 record still lists
NCT04757298 is an interventional study that assigns participants to a tested intervention. The registered 668 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% lower).
The record links to 0 conditions, and to 4 interventions - of which Navigation Services is the first listed.
NCT04757298 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04757298 about?
NCT04757298 is a clinical study titled "Optimization of a New Adaptive Intervention to Increase COVID-19 Testing". This study tests an adaptation of the HIV Continuum of Prevention, Care, and Treatment Framework (CoPCT) for use in tracking COVID-19 testing and follow-up in a medically and socially vulnerable population. This study uses an integrated research collaborative framework that facilitates dialogue amon...
What is the current status of trial NCT04757298?
This trial is currently completed. It is a NA study. The enrollment target is 668 participants. The study started on 2021-02-12. Estimated completion is 2022-10-25.
What interventions are being tested in trial NCT04757298?
The interventions under investigation include: Navigation Services (BEHAVIORAL), Brief Counseling (BEHAVIORAL), Critical Dialogue (BEHAVIORAL), Referral and Digital Brochure (BEHAVIORAL).
Who is sponsoring clinical trial NCT04757298?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04757298's enrollment target sits among peer trials
668 154th of 2000 higher than 1,846 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04155034 · 668 participants · Phase 3
S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer
- NCT04179981 · 668 participants · NA
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
- NCT05006482 · 668 participants · Phase 3
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
- NCT02984761 · 670 participants · NA
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI